These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 8076505

  • 1. [The therapy of cutaneous and mucocutaneous leishmaniasis].
    Blum J, Hatz C, Junghanss T.
    Dtsch Med Wochenschr; 1994 Aug 26; 119(34-35):1169-72. PubMed ID: 8076505
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of New World cutaneous and mucosal leishmaniases.
    Berman JD.
    Clin Dermatol; 1996 Aug 26; 14(5):519-22. PubMed ID: 8889330
    [Abstract] [Full Text] [Related]

  • 3. [Cutaneous leishmaniasis and leishmania species in French Guiana].
    Raccurt CP.
    Med Trop (Mars); 1996 Aug 26; 56(4):415. PubMed ID: 9139207
    [No Abstract] [Full Text] [Related]

  • 4. First case of cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis in Suriname.
    Hu RV, Kent AD, Adams ER, van der Veer C, Sabajo LO, Mans DR, de Vries HJ, Schallig HD, Lai A Fat RF.
    Am J Trop Med Hyg; 2012 May 26; 86(5):825-7. PubMed ID: 22556081
    [Abstract] [Full Text] [Related]

  • 5. [Experimental models of cutaneous leishmaniasis in laboratory animals].
    Pleskanovskaia SA.
    Parazitologiia; 1986 May 26; 20(2):120-5. PubMed ID: 3714297
    [Abstract] [Full Text] [Related]

  • 6. Immunotherapy as a treatment of American cutaneous leishmaniasis: preliminary studies in Brazil.
    Mayrink W, Magalhaes PA, Michalick MS, da Costa CA, Lima Ade O, Melo MN, Toledo VP, Nascimento E, Dias M, Genaro O.
    Parassitologia; 1992 Dec 26; 34(1-3):159-65. PubMed ID: 1339971
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of mucocutaneous leishmaniasis with pentamidine isothionate].
    Amato V, Amato J, Nicodemo A, Uip D, Amato-Neto V, Duarte M.
    Ann Dermatol Venereol; 1998 Aug 26; 125(8):492-5. PubMed ID: 9747313
    [Abstract] [Full Text] [Related]

  • 8. Targeted gene expression profiling in Leishmania braziliensis and Leishmania guyanensis parasites isolated from Brazilian patients with different antimonial treatment outcomes.
    Torres DC, Adaui V, Ribeiro-Alves M, Romero GA, Arévalo J, Cupolillo E, Dujardin JC.
    Infect Genet Evol; 2010 Aug 26; 10(6):727-33. PubMed ID: 20478409
    [Abstract] [Full Text] [Related]

  • 9. Antibody response in patients with cutaneous leishmaniasis infected by Leishmania (Viannia) braziliensis or Leishmania (Viannia) guyanensis in Brazil.
    Romero GA, de la Glória Orge Orge M, de Farias Guerra MV, Paes MG, de Oliveira Macêdo V, de Carvalho EM.
    Acta Trop; 2005 Jan 26; 93(1):49-56. PubMed ID: 15589797
    [Abstract] [Full Text] [Related]

  • 10. New World and Old World Leishmania Infections: A Practical Review.
    Kevric I, Cappel MA, Keeling JH.
    Dermatol Clin; 2015 Jul 26; 33(3):579-93. PubMed ID: 26143433
    [Abstract] [Full Text] [Related]

  • 11. Cutaneous leishmaniasis treatment.
    Minodier P, Parola P.
    Travel Med Infect Dis; 2007 May 26; 5(3):150-8. PubMed ID: 17448941
    [Abstract] [Full Text] [Related]

  • 12. [Identification of Leishmania (V) guyanensis during recurrences of cutaneous leishmaniasis contracted in French Guyana].
    Larriviere-Chouc C, De Pina JJ, Faraut-Gambarelli F, Morillon M, Normand P.
    Med Trop (Mars); 1996 May 26; 56(3):309. PubMed ID: 9026604
    [No Abstract] [Full Text] [Related]

  • 13. Cutaneous leishmaniasis following local trauma: a clinical pearl.
    Wortmann GW, Aronson NE, Miller RS, Blazes D, Oster CN.
    Clin Infect Dis; 2000 Jul 26; 31(1):199-201. PubMed ID: 10913426
    [Abstract] [Full Text] [Related]

  • 14. Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease.
    Grogl M, Thomason TN, Franke ED.
    Am J Trop Med Hyg; 1992 Jul 26; 47(1):117-26. PubMed ID: 1322070
    [Abstract] [Full Text] [Related]

  • 15. Mucosal leishmaniasis . Current scenario and prospects for treatment.
    Amato VS, Tuon FF, Bacha HA, Neto VA, Nicodemo AC.
    Acta Trop; 2008 Jan 26; 105(1):1-9. PubMed ID: 17884002
    [Abstract] [Full Text] [Related]

  • 16. Disseminated cutaneous leishmaniasis due to Leishmania guyanensis: case of a patient with 425 lesions.
    Couppié P, Clyti E, Sainte-Marie D, Dedet JP, Carme B, Pradinaud R.
    Am J Trop Med Hyg; 2004 Nov 26; 71(5):558-60. PubMed ID: 15569784
    [Abstract] [Full Text] [Related]

  • 17. [Mucocutaneous leishmaniasis due to Leishmania guyanensis: a case report in an HIV-infected patient].
    Fourcade S, Huber FI, Blanchet D, Aznar C, Clyti E, Simon S, Sainte-Marie D, Carme B, Couppié P.
    Med Trop (Mars); 2008 Oct 26; 68(5):533-6. PubMed ID: 19068990
    [Abstract] [Full Text] [Related]

  • 18. Inhibition by Dications of in vitro growth of Leishmania major and Leishmania tropica: causative agents of old world cutaneous leishmaniasis.
    Rosypal AC, Werbovetz KA, Salem M, Stephens CE, Kumar A, Boykin DW, Hall JE, Tidwell RR.
    J Parasitol; 2008 Jun 26; 94(3):743-9. PubMed ID: 18605790
    [Abstract] [Full Text] [Related]

  • 19. Assessment of drug resistance related genes as candidate markers for treatment outcome prediction of cutaneous leishmaniasis in Brazil.
    Torres DC, Ribeiro-Alves M, Romero GA, Dávila AM, Cupolillo E.
    Acta Trop; 2013 May 26; 126(2):132-41. PubMed ID: 23416123
    [Abstract] [Full Text] [Related]

  • 20. Effect of a juvenile hormone analogue on Leishmania amazonensis and Leishmania braziliensis.
    Esteva M, Maidana C, Sinagra A, Luna C, Ruiz AM, Stoka AM.
    Exp Parasitol; 2005 Jun 26; 110(2):162-4. PubMed ID: 15888299
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.